Avivagen Inc. (TSXV:VIV) “Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, is pleased to announce its first purchase orders of OxC-beta™ Livestock in North America, and is finalizing sales agreements in Mexico with Industrias Melder , S.A. De C.V. (“Industrias Melder” or the “Company”).
“We are very excited to announce our first purchase orders of OxC-beta™ Livestock and Vivamune in Mexico, paving the way for continued distribution and acceptance of our technology in major feed markets worldwide,” said Kym Anthony, C.E.O. of Avivagen. “With annual feed sales of more than 36 million tonnes, compared with 18.2 million for The Philippines, 20.2 million for Thailand and 21.6 Million for Canada, Mexico represents a fast-growing and important market for OxC-beta™ Livestock. We are confident that, as in other markets around the world, the demand for OxC-beta™ Livestock in Mexico and throughout North America will rapidly expand.”
Established in 1949 and located in Guadalajara, Mexico, Industrias Melder is a feed miller that sells commercial feeds to dairy, poultry and swine producers. The Company has placed an order for purchase of 350 kgs of OxC-beta™ Livestock, as well as an order to purchase 1,000 bags of Vivamune to be sold through Super Pet, a chain of retail pet stores that the Company owns and operates.
In addition to these purchase orders, confirmatory testing of OxC-beta™ Livestock with different species is currently underway with Industrias Melder. These commitments followed Avivagen’s recent presentation of OxC-beta™ technology at a technical seminar series hosted by the Mexican Association of Food Producers (AMEPA) in Guadalajara. The AMEPA seminar series was attended by numerous association members consisting of feed and livestock producers.
